Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 25% ± 7% | |
capillary endothelial cell | 11 studies | 31% ± 13% | |
fibroblast | 8 studies | 21% ± 4% | |
connective tissue cell | 5 studies | 28% ± 9% | |
glomerular endothelial cell | 3 studies | 49% ± 5% | |
epithelial cell | 3 studies | 22% ± 5% | |
basal cell | 3 studies | 15% ± 0% | |
secretory cell | 3 studies | 20% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 23% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 3269.14 | 958 / 966 | 98% | 129.22 | 519 / 527 |
esophagus | 99% | 3085.83 | 1436 / 1445 | 98% | 148.37 | 179 / 183 |
ovary | 99% | 2212.18 | 179 / 180 | 97% | 79.01 | 418 / 430 |
thymus | 100% | 3436.10 | 652 / 653 | 97% | 53.01 | 584 / 605 |
uterus | 100% | 3439.44 | 170 / 170 | 96% | 144.37 | 442 / 459 |
bladder | 100% | 4130.29 | 21 / 21 | 94% | 119.07 | 474 / 504 |
kidney | 100% | 5962.04 | 89 / 89 | 91% | 53.18 | 819 / 901 |
stomach | 92% | 1781.03 | 332 / 359 | 95% | 115.47 | 273 / 286 |
lung | 100% | 6846.12 | 578 / 578 | 83% | 74.28 | 953 / 1155 |
breast | 100% | 6544.52 | 459 / 459 | 79% | 27.04 | 883 / 1118 |
adrenal gland | 100% | 3605.05 | 258 / 258 | 78% | 36.48 | 179 / 230 |
skin | 100% | 5965.26 | 1808 / 1809 | 69% | 28.47 | 326 / 472 |
prostate | 100% | 3340.04 | 245 / 245 | 55% | 15.31 | 275 / 502 |
pancreas | 32% | 364.96 | 105 / 328 | 94% | 131.65 | 167 / 178 |
liver | 60% | 789.66 | 136 / 226 | 53% | 24.60 | 216 / 406 |
adipose | 100% | 6820.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4206.78 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 47.38 | 1 / 1 |
heart | 98% | 2359.76 | 844 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 143.21 | 44 / 45 |
brain | 19% | 196.83 | 500 / 2642 | 72% | 24.80 | 508 / 705 |
blood vessel | 85% | 1485.78 | 1131 / 1335 | 0% | 0 | 0 / 0 |
muscle | 51% | 582.79 | 412 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 4.53 | 6 / 29 |
eye | 0% | 0 | 0 / 0 | 11% | 2.26 | 9 / 80 |
peripheral blood | 0% | 3.26 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0001755 | Biological process | neural crest cell migration |
GO_0042098 | Biological process | T cell proliferation |
GO_0031295 | Biological process | T cell costimulation |
GO_0007155 | Biological process | cell adhesion |
GO_0007267 | Biological process | cell-cell signaling |
GO_0009880 | Biological process | embryonic pattern specification |
GO_2000785 | Biological process | regulation of autophagosome assembly |
GO_0007411 | Biological process | axon guidance |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0070062 | Cellular component | extracellular exosome |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0009986 | Cellular component | cell surface |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0046875 | Molecular function | ephrin receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | EFNB1 |
Protein name | Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment (Ephrin-B1 CTF); Ephrin-B1 intracellular domain (Ephrin-B1 ICD)] |
Synonyms | EPLG2 LERK2 EFL3 |
Description | FUNCTION: Cell surface transmembrane ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development . Binding to Eph receptors residing on adjacent cells leads to contact-dependent bidirectional signaling into neighboring cells . Shows high affinity for the receptor tyrosine kinase EPHB1/ELK . Can also bind EPHB2 and EPHB3 . Binds to, and induces collapse of, commissural axons/growth cones in vitro (By similarity). May play a role in constraining the orientation of longitudinally projecting axons (By similarity). . |
Accessions | P98172 ENST00000204961.5 |